There is no official recommended daily allowance specifically for vitamin K2 in children. Government nutrition guidelines set an “adequate intake” for total vitamin K (mostly based on vitamin K1 data), which ranges from about 30 micrograms per day for toddlers up to 75 micrograms for teenagers. But K2 is a different molecule with distinct behavior in the body, and the only controlled trial in healthy children used 45 micrograms of MK-7, a specific form of K2, and found clear improvements in bone-related markers after just eight weeks. That number has become the most commonly referenced benchmark for pediatric K2 supplementation, though the science is still catching up to the supplement aisle.
Why No Government Has Set a K2-Specific Number
Vitamin K comes in two main forms. K1, found in leafy greens, is the form that governments used when they established intake guidelines decades ago. K2, a family of molecules produced by bacteria during fermentation and found in foods like cheese and natto, was largely lumped in with K1. The two forms differ in how they are absorbed, where they go in the body, and how long they stay active. K1 heads mostly to the liver, where it supports blood clotting. K2 has a longer half-life and travels to tissues outside the liver, including bones and blood vessels.1PubMed Central. Vitamin K: Double Bonds beyond Coagulation Insights into Differences between Vitamin K1 and K2 in Health and Disease Because researchers are still defining what “enough K2” looks like for different age groups, no health authority has carved out a separate daily target for it.
The existing adequate intake values for total vitamin K in children (set by groups like the U.S. Institute of Medicine) were based primarily on the amount of K1 needed to maintain normal blood clotting. They were not designed to address what K2 does in bones, teeth, or the cardiovascular system. That gap in the guidelines is why parents searching for a number tend to find supplement labels and blog posts rather than clear government recommendations.
What the Clinical Evidence in Children Actually Shows
The most direct evidence comes from a randomized, placebo-controlled trial in 55 healthy prepubertal children. Researchers gave one group 45 micrograms of MK-7 daily for eight weeks, while the other group received a placebo. In the supplemented group, circulating levels of MK-7 rose, and a key marker of vitamin K activity in bone improved: the amount of undercarboxylated osteocalcin (an inactive form of a bone protein) dropped, while the active, carboxylated form increased.2PubMed. The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children In plain terms, the children’s bones were doing a better job of using the protein that helps lock calcium into the skeleton.
That 45-microgram figure has become the de facto reference point in pediatric K2 discussions, partly because it is one of the few numbers we have from a well-designed trial in kids. It is a modest dose, well below the pharmacological doses (sometimes 15 milligrams or more of MK-4) used in Japanese osteoporosis treatment for adults. Whether a higher or lower dose would be equally effective, or whether younger or older children need different amounts, remains unanswered. Researchers have noted the need for larger and longer trials, but those studies have been slow to materialize.
How Common Is K2 Insufficiency in Children?
More common than most parents realize. A study measuring bone-related vitamin K markers in healthy children found a pronounced elevation of undercarboxylated osteocalcin compared to adults, suggesting that children’s bones are routinely operating without enough vitamin K to fully activate the proteins involved in mineralization.3PubMed. Pronounced elevation of undercarboxylated osteocalcin in healthy children This does not mean these children had clinical bleeding problems; their clotting was fine. The shortfall was specifically in the extrahepatic tissues, the parts of the body where K2, not K1, does most of its work.
A large cross-sectional study of Chinese children aged 3 to 14 found that roughly 36 percent of boys and 40 percent of girls were K2 insufficient, with seasonal variation (deficiency peaked in spring). The same study observed that girls with precocious puberty had significantly lower levels of both K1 and K2, which the authors hypothesized could be linked to accelerated bone metabolism drawing down available vitamin K faster than diet replenishes it.4Frontiers in Pediatrics. Associations between fat-soluble vitamin status, growth, and development in Chinese children aged 3–14 years: a cross-sectional study These numbers do not translate directly to every population, since diet and sun exposure vary widely, but they reinforce the broader finding that subclinical K2 deficiency in children is not a rare curiosity.
K2 Deficiency and Growth
A recent cross-sectional study looked at the relationship between serum K2 levels and stature in children and found a striking pattern. Among children classified as short for their age, about 81 percent were K2 deficient, compared with roughly 32 percent of children with normal stature. After adjusting for other variables, K2 deficiency was associated with nearly a sixfold increase in the odds of short stature and about a threefold increase in the odds of near-short stature.5PubMed Central. Vitamin K2 deficiency associated with short stature in children: a cross-sectional study
Cross-sectional studies cannot prove that low K2 causes short stature. It is possible that children who are growing poorly also eat less diverse diets, or that some other factor drives both the deficiency and the growth issue. Still, the finding aligns with what we know about K2’s role in activating osteocalcin, a protein directly involved in bone formation and mineralization.6PubMed Central. The Impact of Vitamin K2 (Menaquionones) in Children’s Health and Diseases: A Review of the Literature A skeleton that cannot fully carboxylate osteocalcin has a harder time building itself, and children’s skeletons are building at a pace adults never match.
Which Form of K2 Matters
Vitamin K2 is not one molecule but a family. The two forms you will encounter on supplement labels are MK-4 and MK-7. They behave quite differently once swallowed. A bioavailability study in healthy women showed that MK-4, at a nutritional-level dose, was essentially undetectable in the blood after ingestion. MK-7, on the other hand, was well absorbed and produced measurably higher blood levels that remained elevated for days.7PubMed Central. Comparison of menaquinone-4 and menaquinone-7 bioavailability in healthy women MK-7’s longer half-life means it circulates long enough to reach bones, arteries, and other extrahepatic tissues where K2’s effects are most relevant.
This does not mean MK-4 is useless. At pharmacological doses (milligrams rather than micrograms), MK-4 has shown effects on bone density in some adult studies. But at the kinds of doses found in food or children’s supplements (tens to hundreds of micrograms), MK-7 appears to be far more effective at actually reaching the tissues that need it. The pediatric trial that used 45 micrograms specifically chose MK-7, and most pediatric supplement products on the market follow that lead.
Food Sources That Actually Deliver K2
K2 shows up in the diet primarily through fermented foods and animal products. Natto, a Japanese fermented soybean dish, is the richest food source by a wide margin, delivering hundreds of micrograms of MK-7 per serving. Most children outside Japan, however, find natto’s slimy texture and strong flavor unappealing, to put it mildly.
Cheese is a more realistic option for many families, though the K2 content varies dramatically by type. Cheeses made with certain bacterial cultures contain meaningful amounts of various menaquinone forms. Researchers analyzing Swiss and French cheeses found that Vacherin and Raclette contained median levels of MK-9 around 149 to 167 micrograms per kilogram, with additional MK-8. Emmental had different profiles depending on aging, with older wheels containing substantially more menaquinones than young cheese.8International Dairy Journal. Determination of menaquinone production by Lactococcus spp. and propionibacteria in cheese Other dietary sources include egg yolks, chicken liver, butter from grass-fed cows, and certain fermented vegetables. But the amounts are generally modest, and a child would need to eat a lot of cheese or egg yolks daily to consistently reach 45 micrograms of MK-7 from food alone.
Gut bacteria also produce some menaquinones, which is occasionally cited as a reason not to worry about dietary K2 intake. The reality is more complicated. While colonic bacteria do synthesize K2 forms, the extent to which these are absorbed and used by the body remains unclear, and it almost certainly varies by the composition of a child’s microbiome, which shifts significantly during childhood.
Children With Conditions That Increase Risk
Some children face a much steeper K2 deficit because of underlying health conditions that impair fat absorption. Cystic fibrosis is the most studied example. Because CF disrupts pancreatic enzyme secretion and bile acid metabolism, fat-soluble vitamins (A, D, E, and K) are poorly absorbed. A study of 93 children with CF found that 70 percent had suboptimal vitamin K status based on low serum K1 levels, elevated markers of K deficiency, or both. The researchers recommended that routine vitamin K supplementation be considered for all CF patients.9Pediatrics. Vitamin K Status Among Children With Cystic Fibrosis and Its Relationship to Bone Mineral Density and Bone Turnover A Cochrane review confirmed that fat-soluble vitamin malabsorption is a recognized feature of the disease.10PubMed Central. Vitamin K supplementation for cystic fibrosis
Inflammatory bowel disease is another concern. Children with IBD, particularly Crohn’s disease, may be K-deficient due to a combination of poor nutrient intake, malabsorption, and disrupted gut bacteria from antibiotic use. Research has found that vitamin K deficiency correlates with disease activity in pediatric Crohn’s, with sicker children showing more pronounced deficiency. There is also a hypothesis that K’s potential anti-inflammatory properties mean that being deficient worsens the cycle of inflammation and malabsorption.11Scientific Reports. Prevalence and correlates of vitamin K deficiency in children with inflammatory bowel disease
Children on prolonged antibiotic courses, those with celiac disease, or those with other fat-malabsorption conditions likely face similar challenges, though the evidence base is thinner. For any child with a chronic condition that affects the gut or fat digestion, vitamin K status is worth discussing with a healthcare provider rather than assuming a standard diet is sufficient.
The Vitamin D and K2 Connection
Vitamin D and K2 are often sold together in children’s supplements, and the pairing has a biological rationale beyond marketing. Vitamin D promotes the production of certain proteins, including osteocalcin in bone and matrix Gla protein in blood vessels. But these proteins are made in an inactive form. They need vitamin K2 to undergo a chemical activation step (carboxylation) before they can actually do their jobs. A narrative review of the available evidence concluded that combined supplementation of vitamins D and K appears more effective for bone and cardiovascular health than supplementation with either vitamin alone.12PubMed Central. The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review
The practical implication for parents is that giving a child vitamin D without adequate K2 might increase the production of proteins that then sit around in their inactive form, unable to direct calcium into bones. Some researchers have speculated that high-dose vitamin D supplementation without K2 could even contribute to soft-tissue calcification in the long run, though this concern is more theoretical than proven in pediatric populations. Regardless, if your child is taking a vitamin D supplement (as many do, especially in northern latitudes), ensuring some K2 is part of the picture makes metabolic sense.
Beyond Bones and Blood Clotting
Most of the attention around K2 in children focuses on bone development, and understandably so. But the review literature on K2 in pediatric health lists a broader set of functions for vitamin K-dependent proteins, including contributions to dental health, brain development, joint health, and the regulation of body weight.6PubMed Central. The Impact of Vitamin K2 (Menaquionones) in Children’s Health and Diseases: A Review of the Literature The evidence base for these roles in children specifically is thinner than for bone health, but the proteins involved (particularly osteocalcin and matrix Gla protein) are known to be active in multiple tissue types.
Vitamin K2 also activates matrix Gla protein, which is considered the strongest natural inhibitor of vascular calcification.13BMJ Open. Vitamin K2—a neglected player in cardiovascular health: a narrative review While parents do not typically worry about arterial calcification in a seven-year-old, the vascular system begins developing habits early, and some researchers argue that lifelong K2 adequacy starting in childhood could have long-term cardiovascular benefits. That is a reasonable hypothesis, though long-term pediatric data to confirm it do not yet exist.
Practical Guidance for Parents
Given the absence of an official K2 recommendation for children, parents are left to piece together a sensible approach from the available evidence. A few practical points stand out from the research.
- 45 mcg of MK-7: This is the only dose tested in a randomized controlled trial in healthy children, and it showed meaningful improvements in bone protein activation. Most children’s K2 supplements on the market offer doses in this range, typically 25 to 50 micrograms of MK-7.
- Take it with fat: K2 is fat-soluble, meaning it absorbs best when consumed alongside a meal containing some dietary fat. A supplement taken on an empty stomach will not absorb as well.
- Safety profile: Vitamin K2 has not shown toxicity even at doses well above the amounts found in supplements. No upper limit has been established by major health agencies. The main theoretical concern is for children taking blood-thinning medications like warfarin, which works by blocking vitamin K activity. In that specific situation, any K2 supplementation should be managed by a physician.
- Food first, supplement as backup: Regular consumption of fermented dairy, egg yolks, and (if tolerated) fermented soy provides K2 naturally. A supplement makes sense as insurance for picky eaters or children with limited access to these foods.
The honest state of the science is that we have a biologically plausible dose (45 micrograms of MK-7), a single well-designed trial showing it works in healthy kids, and a growing body of observational evidence that many children are not getting enough. What we lack are large-scale, long-term trials that would let a health authority confidently stamp a specific number on a guidelines document. Until those exist, the available evidence points to MK-7 in the range of 45 micrograms per day as a reasonable and well-supported starting point for most children.
Newborn Vitamin K and How It Differs
Parents researching vitamin K for children sometimes encounter information about the vitamin K injection given to newborns and wonder whether it is related. The connection is indirect. Newborns are born with very low vitamin K stores and limited gut bacteria to produce it, which puts them at risk for a rare but serious bleeding condition. The prophylactic injection given at birth has been standard practice for decades and is overwhelmingly vitamin K1, administered to support clotting in those vulnerable first weeks of life.14PubMed Central. Vitamin K deficiency bleeding: early history and recent trends in the United Kingdom The dose, form, and purpose are completely different from the ongoing K2 supplementation discussed above. Newborn prophylaxis addresses an acute bleeding risk; K2 supplementation in older children supports bone and tissue development over months and years. The two are not interchangeable and should not be confused in decision-making.